Literature DB >> 35048995

Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice.

B Jiang1, Y Shi, M B Abou, L Xu, G Liang, H Wei.   

Abstract

OBJECTIVE: We have previously shown that the intranasal administration of dantrolene ameliorated cognitive dysfunction in the 5XFAD mouse model of Alzheimer's disease. This study examines the morphology of the nasal mucosa after 10 months of intranasal dantrolene in 5XFAD mice.
MATERIALS AND METHODS: 5XFAD mice were either treated with intranasal dantrolene (5 mg/kg, 3 times/wk) from 2 months to 12 months of age or given no treatment at all. The mice were euthanatized at 12 months of age and the snouts were processed for histological examination. The morphology of the nasal mucosa was assessed and compared between the two groups.
RESULTS: There were no significant differences in the thickness of the olfactory epithelium or the proportion of the thickness of the glandular layer to the wall of mucosa and submucosa in the nasal passages.
CONCLUSIONS: Long-term intranasal administration of dantrolene did not significantly change the nasal mucosa morphology in 5XFAD mice.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35048995      PMCID: PMC9338757          DOI: 10.26355/eurrev_202201_27768

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.784


  19 in total

1.  Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals.

Authors:  J F Hardisty; R H Garman; J R Harkema; L G Lomax; K T Morgan
Journal:  Toxicol Pathol       Date:  1999 Nov-Dec       Impact factor: 1.902

2.  Evaluation of the Reid index in infants and cases of SIDS.

Authors:  B Karger; T Fracasso; B Brinkmann; T Bajanowski
Journal:  Int J Legal Med       Date:  2004-01-16       Impact factor: 2.686

3.  Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.

Authors:  Alain Lacampagne; Xiaoping Liu; Steven Reiken; Renaud Bussiere; Albano C Meli; Inger Lauritzen; Andrew F Teich; Ran Zalk; Nathalie Saint; Ottavio Arancio; Charlotte Bauer; Fabrice Duprat; Clark A Briggs; Shreaya Chakroborty; Grace E Stutzmann; Michael L Shelanski; Frederic Checler; Mounia Chami; Andrew R Marks
Journal:  Acta Neuropathol       Date:  2017-06-19       Impact factor: 17.088

4.  Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Authors:  Bénédicte Oulès; Dolores Del Prete; Barbara Greco; Xuexin Zhang; Inger Lauritzen; Jean Sevalle; Sebastien Moreno; Patrizia Paterlini-Bréchot; Mohamed Trebak; Frédéric Checler; Fabio Benfenati; Mounia Chami
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

5.  Manual hematoxylin and eosin staining of mouse tissue sections.

Authors:  Robert D Cardiff; Claramae H Miller; Robert J Munn
Journal:  Cold Spring Harb Protoc       Date:  2014-06-02

6.  The effects of naris occlusion on mouse nasal turbinate development.

Authors:  David M Coppola; Brent A Craven; Johannes Seeger; Elke Weiler
Journal:  J Exp Biol       Date:  2013-12-05       Impact factor: 3.312

Review 7.  Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.

Authors:  D P Rice; H M Fillit; W Max; D S Knopman; J R Lloyd; S Duttagupta
Journal:  Am J Manag Care       Date:  2001-08       Impact factor: 2.229

Review 8.  Effects of dantrolene on ischemia-reperfusion injury in animal models: a review of outcomes in heart, brain, liver, and kidney.

Authors:  Joshua A Boys; Alexander H Toledo; Roberto Anaya-Prado; Fernando Lopez-Neblina; Luis H Toledo-Pereyra
Journal:  J Investig Med       Date:  2010-10       Impact factor: 2.895

9.  Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.

Authors:  Xi Chen; Tie-Shan Tang; Huiping Tu; Omar Nelson; Mark Pook; Robert Hammer; Nobuyuki Nukina; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

10.  Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.

Authors:  Yun Shi; Lei Zhang; Xue Gao; Jing Zhang; Matan Ben Abou; Ge Liang; Qingcheng Meng; Adrian Hepner; Maryellen F Eckenhoff; Huafeng Wei
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.